aftera

Generic: levonorgestrel

Labeler: foundation consumer healthcare llc
NDC Directory HUMAN OTC DRUG NDA AUTHORIZED GENERIC Inactive Finished

Drug Facts

Product Profile

Brand Name aftera
Generic Name levonorgestrel
Labeler foundation consumer healthcare llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

levonorgestrel 1.5 mg/1

Manufacturer
Foundation Consumer Healthcare LLC

Identifiers & Regulatory

Product NDC 69536-103
Product ID 69536-103_3a89dc68-ce64-462c-8040-2f21f57b6f28
Product Type HUMAN OTC DRUG
Marketing Category NDA AUTHORIZED GENERIC
Application Number NDA021998
Listing Expiration 2026-12-31
Marketing Start 2018-05-10

Pharmacologic Class

Established (EPC)
progestin [epc] progestin-containing intrauterine system [epc]
Chemical Structure
progesterone congeners [cs]
Physiologic Effect
inhibit ovum fertilization [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69536103
Hyphenated Format 69536-103

Supplemental Identifiers

RxCUI
483325 1598658
UPC
0369536103884
UNII
5W7SIA7YZW
NUI
N0000175830 M0447349 N0000175602 N0000175832

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name aftera (source: ndc)
Generic Name levonorgestrel (source: ndc)
Application Number NDA021998 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 1.5 mg/1
source: ndc
Packaging
  • 1 BLISTER PACK in 1 BOX, UNIT-DOSE (69536-103-88) / 1 TABLET in 1 BLISTER PACK
source: ndc

Packages (1)

Ingredients (1)

levonorgestrel (1.5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3a89dc68-ce64-462c-8040-2f21f57b6f28", "openfda": {"nui": ["N0000175830", "M0447349", "N0000175602", "N0000175832"], "upc": ["0369536103884"], "unii": ["5W7SIA7YZW"], "rxcui": ["483325", "1598658"], "spl_set_id": ["53ad8dff-9134-475c-90b3-8087753e17c4"], "pharm_class_cs": ["Progesterone Congeners [CS]"], "pharm_class_pe": ["Inhibit Ovum Fertilization [PE]"], "pharm_class_epc": ["Progestin [EPC]", "Progestin-containing Intrauterine System [EPC]"], "manufacturer_name": ["Foundation Consumer Healthcare LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BLISTER PACK in 1 BOX, UNIT-DOSE (69536-103-88)  / 1 TABLET in 1 BLISTER PACK", "package_ndc": "69536-103-88", "marketing_start_date": "20180510"}], "brand_name": "Aftera", "product_id": "69536-103_3a89dc68-ce64-462c-8040-2f21f57b6f28", "dosage_form": "TABLET", "pharm_class": ["Inhibit Ovum Fertilization [PE]", "Progesterone Congeners [CS]", "Progesterone Congeners [CS]", "Progestin [EPC]", "Progestin-containing Intrauterine Device [EPC]"], "product_ndc": "69536-103", "generic_name": "LEVONORGESTREL", "labeler_name": "Foundation Consumer Healthcare LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Aftera", "active_ingredients": [{"name": "LEVONORGESTREL", "strength": "1.5 mg/1"}], "application_number": "NDA021998", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20180510", "listing_expiration_date": "20261231"}